Activation of natural killer cells during acute infection with hepatitis C virus
…, S Urbani, A Cazaly, P Fisicaro, A Zerbini, P Ahmed… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: Natural killer (NK) cells are essential early after infection, not only
for viral containment but also for timely and efficient induction of adaptive responses. An …
for viral containment but also for timely and efficient induction of adaptive responses. An …
Peptide antagonism as a mechanism for NK cell activation
L Fadda, G Borhis, P Ahmed… - Proceedings of the …, 2010 - National Acad Sciences
Inhibition of natural killer (NK) cells is mediated by MHC class I receptors including the killer
cell Ig-like receptor (KIR). We demonstrate that HLA-C binding peptides can function as …
cell Ig-like receptor (KIR). We demonstrate that HLA-C binding peptides can function as …
Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase
A Lau, KM Swinbank, PS Ahmed, DL Taylor… - Nature cell …, 2005 - nature.com
Chemotherapy that is used to treat human immunodeficiency virus type-1 (HIV-1) infection
focuses primarily on targeting virally encoded proteins. However, the combination of a short …
focuses primarily on targeting virally encoded proteins. However, the combination of a short …
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study
…, S Brandner, P Jat, A Nihat, TH Mok, P Ahmed… - The Lancet …, 2020 - thelancet.com
Background Human prion diseases are rare and usually rapidly fatal neurodegenerative
disorders, the most common being sporadic Creutzfeldt-Jakob disease (sCJD). Variants in the …
disorders, the most common being sporadic Creutzfeldt-Jakob disease (sCJD). Variants in the …
Action of Celgosivir (6 O-Butanoyl Castanospermine) against the Pestivirus BVDV: Implications for the Treatment of Hepatitis C
…, D Taylor, D Patel, P Ahmed… - Antiviral Chemistry …, 2004 - journals.sagepub.com
α-Glucosidase I inhibitors have been shown to inhibit the replication of a broad range of
enveloped viruses by preventing the correct folding of their envelope glycoproteins. This study …
enveloped viruses by preventing the correct folding of their envelope glycoproteins. This study …
Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2′-deoxy-3′-oxa-4′-thiocytidine
…, N Nguyen-Ba, DL Taylor, PS Ahmed… - Antimicrobial agents …, 1999 - Am Soc Microbiol
The racemic nucleoside analogue 2′-deoxy-3′-oxa-4′-thiocytidine (dOTC) is in clinical
development for the treatment of human immunodeficiency virus (HIV) type 1 (HIV-1) infection…
development for the treatment of human immunodeficiency virus (HIV) type 1 (HIV-1) infection…
A peptide antagonist disrupts NK cell inhibitory synapse formation
G Borhis, PS Ahmed, B Mbiribindi… - The Journal of …, 2013 - journals.aai.org
Productive engagement of MHC class I by inhibitory NK cell receptors depends on the peptide
bound by the MHC class I molecule. Peptide: MHC complexes that bind weakly to killer …
bound by the MHC class I molecule. Peptide: MHC complexes that bind weakly to killer …
[HTML][HTML] A high-content neuron imaging assay demonstrates inhibition of prion disease-associated neurotoxicity by an anti-prion protein antibody
…, I Benilova, A Khalili-Shirazi, C Schmidt, P Ahmed… - Scientific Reports, 2022 - nature.com
There is an urgent need to develop disease-modifying therapies to treat neurodegenerative
diseases which pose increasing challenges to global healthcare systems. Prion diseases, …
diseases which pose increasing challenges to global healthcare systems. Prion diseases, …
Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(±)-2′-deoxy-3′-oxa-4′-thiocytidine, dOTC]
DL Taylor, PS Ahmed, AS Tyms… - Antiviral Chemistry …, 2000 - journals.sagepub.com
The heterosubstituted nucleoside analogue dOTC [(±)-2′-deoxy-3′-oxa-4′-thiocytidine,
BCH-10652] is a racemic compound structurally related to 3TC (lamivudine), but has the …
BCH-10652] is a racemic compound structurally related to 3TC (lamivudine), but has the …
The effect of oral treatment with 6-O-butanoyl castanospermine (MDL 28,574) in the murine zosteriform model of HSV-1 infection
CG Bridges, SP Ahmed, MS Kang, RJ Nash… - …, 1995 - academic.oup.com
Oral treatment of mice, cutaneously infected with herpes simplex virus type 1 (HSV-1) (strain
SC16), with the α-gluco-sidase 1 inhibitor 6-O-butanoyl castanospermine (MDL 28,574) …
SC16), with the α-gluco-sidase 1 inhibitor 6-O-butanoyl castanospermine (MDL 28,574) …